Ambry Genetics

Danielle Rogers is an oncology and genetics nurse practitioner who serves as a genetic counseling resource for patients from a variety of clinics in Florida. She recently shared some of her experiences. Hear how personalized cancer risk assessments improved after the implementation of the Ambry CARE Program®. hubs.ly/Q0482zTM0

Need help making sense of how sequencing approaches in hereditary cancer have evolved and where they are heading? Our new review article breaks down the strengths and future directions of these technologies to help clinicians and researchers stay informed. hubs.ly/Q0486vnj0

Each week, we explore a gene from the ACMG Secondary Findings list. This week, join Rachel Bluebond, MMSc, CGC, as she explores SMAD4 and its associated conditions of juvenile polyposis syndrome (JPS) and Myhre syndrome. Dive deeper: hubs.ly/Q0482G_r0 #GeneScene #GeneChat #SMAD4

Noelle Carbognin has a message for #LynchSyndromeAwarenessDay. Passionate about precision medicine and patient advocacy, she is not only knowledgeable about the difference Ambry's genetic tests can make, but she has lived it. Listen to part of her previvor story that she shared on Doctor Radio.

Ambry Genetics is proud to share newly published data describing duoNovo, a tool that uses long‑read sequencing to identify de novo variants from parent–proband duos—expanding diagnostic options when only one parent is available. This work, produced in collaboration with the GREGoR consortium, promises to improve equity and access to genetic diagnosis for families who previously lacked both‑parent sequencing. hubs.ly/Q047mdqj0

Smarter screening and prevention start with risk insights. Don’t miss these opportunities at #NCoBC2026 to learn more about how the Ambry CARE Program® helps centers strengthen high-risk patient identification. hubs.ly/Q0477tK-0

Genomic testing is going mainstream, but is it going equitable? 🧬⚖️ We spoke with @AmbryGenetics at #ACMGMtg2026 about the vital difference between equitable access and accuracy. Links below to stream or search "DNA Today" in your pod app. #HealthEquity #Genomics

Join us for a webinar on Wednesday, March 25, at 10 am PDT. Explore the current landscape of genomic literacy and discuss practical strategies for improving understanding across the communities most impacted by these technologies. #EducateNext #CEU #GeneChat hubs.ly/Q046Wzkr0

We’re excited to share that Ambry’s hereditary cancer testing turnaround times are faster than ever before, helping you make timely, confident decisions for your patients.  Our BRCAplus® STAT test now delivers results in just 4–7 days, providing rapid insights when time matters most. In addition, our other hereditary cancer panels now have a 5–14 day turnaround time, offering both speed and comprehensive coverage across indications. Learn more: hubs.ly/Q046Wtv70

Haaniya Mallick, MS, CGC, joins us for The Gene Scene where we explore the clinical recommendations for a gene from the ACMG Secondary Findings list. This week, she breaks down CASQ2 and its link to CASQ2-related catecholaminergic polymorphic ventricular tachycardia (CPVT). hubs.ly/Q046Wr7l0

ICYMI: Join Ambry experts and @KiraDineen from @DNATodayPodcast to get the recap on #ACMGMtg2026 with industry insights into whole genome sequencing, AI, and more! hubs.ly/Q046XXtL0

Ambry account executive Noelle Carbognin shared her family's story for #ColorectalCancerAwarenessMonth and #LynchSyndromeAwarenessDay. Watch the inspiring video below and then 🌊dive deeper with these Ambry blogs. Explore the importance of advocating for your health and knowing your family history #genetictesting #coloncancer #Lynchsydrome hubs.ly/Q046Mt7P0 hubs.ly/Q046MnDL0 hubs.ly/Q046Mpt10

Ambry is proud to support the Child Neurology Foundation as a Champion Level Partner. Read the press release: hubs.ly/Q046tf1S0

Ambry Genetics is in Baltimore for #ACMGMtg26! We look forward to seeing you at our theater presentation on Friday, and make sure you stop by booth 517 to learn more about Ambry's #exome testing and Patient for Life™. For a full list of our posters or to schedule time to meet with our experts to discuss where genomic insights meet clinical action, visit hubs.ly/Q046cZtn0

We know you want to find answers for patients. Discover how Ambry was able to give one patient actionable results through MAVEs data and the Ambry Classifi® program. hubs.ly/Q0462J4J0

In this Gene Scene, Katherine Crawford covers gene-disease validity in the CALM2 gene including CALM2–related calmodulinopathy with clinical considerations for genetic counselors. Dive deeper: hubs.ly/Q0462ybg0 #GeneScene #GeneChat

Headed to #AMCG2026? Meet the experts at our booth. Set up a meeting here: hubs.ly/Q045dpbh0 Thursday, March 12: 3:00 - 4:00pm Carrie Horton, MS: In her role as a Clinical Strategy Manager for Research and Collaborations, Carrie works to aligning our research strategies with unmet clinical needs and to ensure that our findings are amplified to reach the right audience. In particular, Carrie is interested in exploring proactive steps labs can take to promote genomic test equity and improve access for all patient populations. Stephany Tandy, MS: Stephany is a Principal Clinical Genomic Scientist leading Ambry’s Patient for Life program. The Patient for Life team continuously reviews previously tested patients for any updated information that could impact results and patient care. Come meet Stephany to learn more about how Ambry’s exciting Patient for Life program will benefit your patients for the rest of their lives. Thursday, March 12: 3:00 - 4:00pm and Saturday, March 14: 8:00 - 9:30am Matthew Schultz, PhD: As Director of Bioinformatics, Matthew Schultz, PhD, focuses on developing computational and statistical methods that transform large-scale genomic data into meaningful clinical insights. He is particularly dedicated to leveraging pangenomes to address the technical challenges of genomic equity, working to build robust bioinformatics solutions that overcome bias and ensure accurate, actionable results for all patient populations.

Are you a pediatric NP working in primary care, developmental pediatrics, or autism‑focused settings who wants to better understand how genetic testing can support earlier diagnoses, guide care decisions, and improve outcomes for your patients and their families? Register now for a webinar on April 8 at 10:00 AM PST / 1:00 PM EST. hubs.ly/Q045T_M40 Pediatric nurse practitioner Lexi Vierling, CPNP, PMH, and genetic counselor Aubrey Rose, MS, CGC, will walk through how you can: 1. Identify clinical scenarios in which genetic testing should be considered for children with neurodevelopmental conditions, including developmental delay, autism, intellectual disability, epilepsy, and hypotonia 2. Describe key differences among commonly used genetic tests 3. Implement a practical, clinic‑ready genetic testing workflow.

We are looking forward to #ACMG2026 and discussing where genomic insights meet clinical action. Meet Seth Berger, MD, PhD, Translational Genomics Director for Rare Disease in Research and Development at Ambry and get a sneak peak of industry insights in this blog and then ask him your questions at booth 517. Dive deeper: hubs.ly/Q045y-lZ0

Don't miss our exhibit theater presentation on Friday, March 13. Join Dr. Altovise Ewing-Crawford, Dr. Seth Berger, and Carrie Horton, MS, CGC to explore laboratory-led initiatives that improve equity in genomic testing. Check out all of our scientific posters or make an appointment to meet our experts in booth 517. hubs.ly/Q045dnN90